Amount Raised
£38 Million
Round Type
Funding Round
Description
Biotech startup Nucleome Therapeutics has raised £37.5m in an oversubscribed Series A round to discover new medicines by decoding the human genome.
Quick answer
Nucleome Therapeutics raised £38 Million in a Funding Round round, dated October 20, 2022. Nucleome Therapeutics is based in Oxford, England, United Kingdom.
- How much did Nucleome Therapeutics raise?
- Nucleome Therapeutics raised £38 Million in a Funding Round round on October 20, 2022.
- What does Nucleome Therapeutics do?
- Nucleome is an immunology company tackling the root causes of disease through a revolutionary new approach to solving human genetics.
- Where is Nucleome Therapeutics based and how big is it?
- Nucleome Therapeutics is based in Oxford, England, United Kingdom.
- Who are the decision-makers at Nucleome Therapeutics?
- Fundz holds 1 contact at Nucleome Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Nucleome Therapeutics, and when
A new round usually means Nucleome Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nucleome Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nucleome Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleome Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleome Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nucleome Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.